Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Mol Neurosci. 2016 Jun 3;59(4):531–543. doi: 10.1007/s12031-016-0774-z

Figure 4.

Figure 4

NGF and BDNF content in the urinary bladders of WT and NGF-OE transgenic mice with or without CYP treatment (4 hours, h). NGF (A) and BDNF (B) content in whole urinary bladder was determined in littermate WT and NGF-OE transgenic mice under control (no CYP) and CYP-treated (4 h) conditions. Samples size are n of 6–8; *, p ≤ 0.05 versus control (no CYP); #, p ≤ 0.05 between WT and NGF-OE.